Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 AUD | -.--% | -.--% | -.--% |
Sales 2024 * | 5.09M 3.31M | Sales 2025 * | 5.09M 3.31M | Capitalization | 16.88M 10.99M |
---|---|---|---|---|---|
Net income 2024 * | -38M -24.75M | Net income 2025 * | -47M -30.61M | EV / Sales 2024 * | 3.32 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.32 x |
P/E ratio 2024 * |
-0.43
x | P/E ratio 2025 * |
-0.28
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 23-01-04 | |
Director of Finance/CFO | 62 | 23-06-30 | |
Chief Tech/Sci/R&D Officer | - | 23-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Wilson
BRD | Director/Board Member | 61 | 16-06-15 |
Alan Fisher
CHM | Chairman | 71 | 16-08-31 |
Jane Ryan
BRD | Director/Board Member | 65 | 20-09-30 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |
- Stock
- Equities
- Stock Bionomics Limited
- Stock Bionomics - Australian S.E.